Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) EBIT Margin (2016 - 2025)

cbdMD's EBIT Margin history spans 10 years, with the latest figure at 5.71% for Q4 2025.

  • On a quarterly basis, EBIT Margin fell 402.0% to 5.71% in Q4 2025 year-over-year; TTM through Dec 2025 was 12.37%, a 49.0% decrease, with the full-year FY2025 number at 11.27%, up 537.0% from a year prior.
  • EBIT Margin hit 5.71% in Q4 2025 for cbdMD, up from 14.53% in the prior quarter.
  • Over the last five years, EBIT Margin for YCBD hit a ceiling of 1.69% in Q4 2024 and a floor of 385.51% in Q2 2022.
  • Historically, EBIT Margin has averaged 76.22% across 5 years, with a median of 30.21% in 2023.
  • Biggest five-year swings in EBIT Margin: plummeted -32230bps in 2022 and later skyrocketed 35730bps in 2023.
  • Tracing YCBD's EBIT Margin over 5 years: stood at 269.74% in 2021, then skyrocketed by 76bps to 64.84% in 2022, then soared by 69bps to 19.83% in 2023, then surged by 91bps to 1.69% in 2024, then crashed by -238bps to 5.71% in 2025.
  • Business Quant data shows EBIT Margin for YCBD at 5.71% in Q4 2025, 14.53% in Q3 2025, and 19.64% in Q2 2025.